Search by First Name and/or Last Name. Results are displayed in descending publication year and then sorted ascending by the reference field. Need to submit a publication reference?
Name: Suzanne Schindler
Year: 2023
Reference:
Cooley SA, Nelson B, Boerwinkle A, Yarasheski KE, Kirmess KM, Meyer MR, Schindler SE, Morris JC, Fagan A, Ances BM, O’Halloran J. Plasma Aβ42/Aβ40 ratios are not reduced in older people living with HIV. Clin Infect Dis. 2023 Jan 5:ciad001. doi: 10.1093/cid/ciad001. Epub ahead of print. PMID: 36610788.
Name: Andrew Aschenbrenner
Year: 2022
Reference:
Aschenbrenner AJ, Li Y, Henson RL, Volluz K, Hassenstab J, Verghese P, West T, Meyer MR, Kirmess KM, Fagan AM, Xiong C, Holtzman D, Morris JC, Bateman RJ, Schindler SE. Comparison of plasma and CSF biomarkers in predicting cognitive decline. Ann Clin Transl Neurol. 2022 Oct 2. doi: 10.1002/acn3.51670. Epub ahead of print. PMID: 36183195.
Format:
Name: Suzanne Schindler
Year: 2022
Reference:
Aschenbrenner AJ, Li Y, Henson RL, Volluz K, Hassenstab J, Verghese P, West T, Meyer MR, Kirmess KM, Fagan AM, Xiong C, Holtzman D, Morris JC, Bateman RJ, Schindler SE. Comparison of plasma and CSF biomarkers in predicting cognitive decline. Ann Clin Transl Neurol. 2022 Oct 2. PMID: 36183195.
Name: Andrew Aschenbrenner
Year: 2022
Reference:
Aschenbrenner AJ, Murphy SA, Doherty JM, Johnson AM, Bayat S, Walker A, Peña Y, Hassenstab J, Morris JC, Babulal GM. Neuropsychological correlates of changes in driving behavior among clinically healthy older adults. J Gerontol B Psychol Sci Soc Sci. 2022 Jul 23:gbac101. doi: 10.1093/geronb/gbac101. Epub ahead of print. PMID: 35869666.
Format:
Name: Suzanne Schindler
Year: 2022
Reference:
Brand AL, Lawler PE, Bollinger JG, Li Y, Schindler SE, Li M, Lopez S, Ovod V, Nakamura A, Shaw LM, Zetterberg H, Hansson O, Bateman RJ. The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review. Alzheimers Res Ther. 2022 Dec 27;14(1):195. doi: 10.1186/s13195-022-01117-1. PMID: 36575454; PMCID: PMC9793600.
Name: Anne Fagan
Year: 2022
Reference:
Casaletto KB, Kornack J, Paolillo EW, Rojas JC, VandeBunte A, Staffaroni AS, Lee S, Heuer H, Forsberg L, Ramos EM, Miller BL, Kramer JH, Yaffe K, Petrucelli L, Boxer A, Boeve B, Gendron TF, Rosen H; ALLFTD Consortium. Association of Physical Activity With Neurofilament Light Chain Trajectories in Autosomal Dominant Frontotemporal Lobar Degeneration Variant Carriers. JAMA Neurol. 2022 Nov 14:e224178. doi: 10.1001/jamaneurol.2022.4178. Epub ahead of print. PMID: 36374516; PMCID: PMC9664369.
Name: Sarah Hartz
Year: 2022
Reference:
Hartz SM, Mozersky J, Schindler SE, Linnenbringer E, Wang J, Gordon BA, Raji CA, Moulder KL, West T, Benzinger TLS, Cruchaga C, Hassenstab JJ, Bierut LJ, Xiong C, Morris JC. A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer’s disease dementia. Alzheimers Dement. 2022 Sep 30. doi: 10.1002/alz.12781. Epub ahead of print. PMID: 36178120.
Name: Suzanne Schindler
Year: 2022
Reference:
Hartz SM, Mozersky J, Schindler SE, Linnenbringer E, Wang J, Gordon BA, Raji CA, Moulder KL, West T, Benzinger TLS, Cruchaga C, Hassenstab JJ, Bierut LJ, Xiong C, Morris JC. A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer’s disease dementia. Alzheimers Dement. 2022 Sep 30. PMID: 36178120.
Name: Anne Fagan
Year: 2022
Reference:
Joseph-Mathurin N, Llibre-Guerra JJ, Li Y, McCullough AA, Hofmann C, Wojtowicz J, Park E, Wang G, Preboske GM, Wang Q, Gordon BA, Chen CD, Flores S, Aggarwal NT, Berman SB, Bird TD, Black SE, Borowski B, Brooks WS, Chhatwal JP, Clarnette R, Cruchaga C, Fagan AM, Farlow M, Fox NC, Gauthier S, Hassenstab J, Hobbs DA, Holdridge KC, Honig LS, Hornbeck RC, Hsiung GR, Jack CR Jr, Jimenez-Velazquez IZ, Jucker M, Klein G, Levin J, Mancini M, Masellis M, McKay NS, Mummery CJ, Ringman JM, Shimada H, Snider BJ, Suzuki K, Wallon D, Xiong C, Yaari R, McDade E, Perrin RJ, Bateman RJ, Salloway SP, Benzinger TLS, Clifford DB; Dominantly Inherited Alzheimer Network Trials Unit. Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease. Ann Neurol. 2022 Nov;92(5):729-744. doi: 10.1002/ana.26511. Epub 2022 Oct 13. PMID: 36151869.
Name: Peter Millar
Year: 2022
Reference:
Millar, PR, Luckett, PH, Gordon, BA, Benzinger, TLS, Schindler, SE, Fagan, AM, Cruchaga, C, Bateman, RJ, …, the Dominantly Inherited Alzheimer Network, Morris, JC, & Ances, BM (2022). Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease. NeuroImage, 256, 119228. DOI: 10.1016/j.neuroimage.2022.119228 PMID: 35452806.
Millar, PR, Gordon, BA, Luckett, PH, Benzinger, TLS, Cruchaga, C, Fagan, AM, Hassenstab, JJ, Perrin, RJ, Schindler, SE, …, the Dominantly Inherited Alzheimer Network, Bateman, RJ, Morris, JC, & Ances, BM (submitted). Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages.
Name: Anne Fagan
Year: 2022
Reference:
O’Connor A, Rice H, Barnes J, Ryan NS, Liu KY, Allegri RF, Berman S, Ringman JM, Cruchaga C, Farlow MR, Hassenstab J, Lee JH, Perrin RJ, Xiong C, Gordon B, Levey AI, Goate A, Graff-Radford N, Levin J, Jucker M, Benzinger T, McDade E, Mori H, Noble JM, Schofield PR, Martins RN, Salloway S, Chhatwal J, Morris JC, Bateman R, Howard R, Reeves S, Fox NC; Dominantly Inherited Alzheimer Network. First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease: the Dominantly Inherited Alzheimer’s Network Study. J Neurol Neurosurg Psychiatry. 2022 Dec 15:jnnp-2022-329843. doi: 10.1136/jnnp-2022-329843. Epub ahead of print. PMID: 36522155.
Name: Suzanne Schindler
Year: 2022
Reference:
Rosen AC, Arias JJ, Ashford JW, Blacker D, Chhatwal JP, Chin NA, Clark L, Denny SS, Goldman JS, Gleason CE, Grill JD, Heidebrink JL, Henderson VW, Lavacot JA, Lingler JH, Menon M, Nosheny RL, Oliveira FF, Parker MW, Rahman-Filipiak A, Revoori A, Rumbaugh MC, Sanchez DL, Schindler SE, Schwarz CG, Toy L, Tyrone J, Walter S, Wang LS, Wijsman EM, Zallen DT, Aggarwal NT. The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All. J Alzheimers Dis. 2022 Jul 31. PMID: 35938255.
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE, Karikari TK, Ashton NJ, Henson RL, Yarasheski KE, West T, Meyer MR, Kirmess KM, Li Y, Saef B, Moulder KL, Bradford D, Fagan AM, Gordon BA, Benzinger TLS, Balls-Berry J, Bateman RJ, Xiong C, Zetterberg H, Blennow K, Morris JC. Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light. Neurology. 2022 Apr 21. PMID: 35450967.
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE, Karikari TK. Comorbidities confound Alzheimer’s blood tests. Nature Med. 2022 Jul 4. PMID: 35788176.
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE, Karikari TK. “Comorbidities confound Alzheimer’s blood tests.” Nature Med. (2022). Schindler, S.E., Karikari, T.K. Comorbidities confound Alzheimer’s blood tests. Nature Med (2022). https://doi.org/10.1038/s41591-022-01875-3.
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE, Li Y, Li M, Despotis A, Park E, Vittert L, Hamilton BH, Womack KB, Saef B, Holtzman DM, Morris JC, Bateman RJ, Gupta MR. Using Alzheimer’s disease blood tests to accelerate clinical trial enrollment. Alzheimers Dement. 2022 Aug 7. PMID: 35934777
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE, Ney DE, Goss AL, Rabinovici G. “ANA Investigates: The Future of Biomarkers in Alzheimer Disease.” Ann Neurol. June 2022; https://doi.org/10.1002/ana.26437.
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE. Predicting Symptom Onset in Sporadic Alzheimer’s Disease: “How Long Do I Have?” J Alzheimers Dis. 2022 Feb 21. PMID: 35213383
Name: Suzanne Schindler
Year: 2022
Reference:
Schindler SE. “Fluid biomarkers in dementia diagnosis.” CONTINUUM Lifelong Learning in Neurology. 2022 June; 28(3):822-833. DOI: 10.1212/CON.0000000000001083.
Name: Marissa Streitz
Year: 2022
Reference:
Streitz ML, Denny A, Xiong C, et al. Development of a Comprehensive Battery to Collect Social and Structural Determinants of Health (SSDOH) in Cognitively Normal or Very Mildly Impaired Persons. Alzheimer Dis Assoc Disord. 2022;36(2):97-102. doi:10.1097/WAD.0000000000000505
Name: Anne Fagan
Year: 2022
Reference:
Wang G, Li Y, Xiong C, McDade E, Clifford DB, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, Libre-Guerra JJ, McCullough A, Joseph-Mathurin N, Chen CD, Mummery C, Wendelberger BA, Gauthier S, Masellis M, Holdridge KC, Yaari R, Chatterjee S, Sims J, Delmar P, Kerchner GA, Bittner T, Hofmann C, Bateman RJ; DIAN‐TU Study Team. Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease. Alzheimers Dement (Amst). 2022 Nov 3;14(1):e12367. doi: 10.1002/dad2.12367. PMID: 36348972; PMCID: PMC9632865.
Name: Suzanne Schindler
Year: 2022
Reference:
Zicha S, Bateman RJ, Shaw LM, Zetterberg H, Bannon AW, Horton WA, Baratta M, Kolb HC, Dobler I, Mordashova Y, Saad ZS, Raunig DL, Spanakis EM, Li Y, Schindler SE, Ferber K, Rubel CE, Martone RL, Weber CJ, Edelmayer RM, Meyers EA, Bollinger JG, Rosenbaugh EG, Potter WZ; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ as a Predictor of Amyloid Positivity in Alzheimer’s Disease Project Team. Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity. Alzheimers Dement. 2022 Jul 12. PMID: 35820077.
Name: Cyrus Raji
Year: 2021
Reference:
Amjad Samara 1, Zhaolong Li 1 2, Jerrel Rutlin 1, Cyrus A Raji 3 4, Peng Sun 3, Sheng-Kwei Song 3, Tamara Hershey 1 3 4, Sarah A Eisenstein 1 3
Nucleus accumbens microstructure mediates the relationship between obesity and eating behavior in adults
Obesity (Silver Spring)
. 2021 Jul 5. doi: 10.1002/oby.23201. Online ahead of print.
PMID: 34227242 DOI: 10.1002/oby.23201
Name: Ganesh Babulal
Year: 2021
Reference:
Babulal GM. Inclusion of ethnoracial populations and diversity remains a key challenge in Alzheimer’s disease biofluid-based biomarker studies. Journal of the Neurological Sciences. 2021; 421:117269. PMID: 33357998
Name: Suzanne Schindler
Year: 2021
Reference:
Boerwinkle AH, Wisch JK, Chen CD, Gordon BA, Butt OH, Schindler SE, Sutphen C, Flores S, Dincer A, Benzinger TLS, Fagan AM, Morris JC, Ances BM. Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease. Neurology. 2021 Apr 30. PMID: 33931538.